Elsevier

Heart Failure Clinics

Volume 16, Issue 4, October 2020, Pages 387-407
Heart Failure Clinics

Predicting High-Risk Patients and High-Risk Outcomes in Heart Failure

https://doi.org/10.1016/j.hfc.2020.05.002Get rights and content

Section snippets

Key points

  • Identifying patients with heart failure who are at high risk for poor outcomes is important for patient care, resource allocation and process improvement.

  • Several risk models exist to identify high-risk patients with heart failure, based on traditional statistical risk modeling methodology.

  • Risk models for heart failure are infrequently used in practice because of their modest performance outside validation cohorts, lack of evidence to support that risk modeling in heart failure improves

Established risk factors for poor outcomes in patients with heart failure

Several demographic and clinical variables have been explored as markers of increased risk for adverse outcomes in HF populations. Risk factors can vary substantially based on the outcome of interest or the population under study. Although a discussion of all of these risk factors is beyond the scope of this article, some of the prognostic features that have been consistently found to be significant drivers of clinically important outcomes, including mortality, hospitalization, and

Multivariable risk models for patients with heart failure

Considerable effort has been devoted to developing multivariable risk scores to help summarize and simplify risk assessment so that it can be performed in real time in a clinical setting or embedded into systems of care. To date, hundreds of multivariable risk scores for predicting outcomes in HF populations have been developed. Most of these risk models have been derived from multivariable statistical modeling, such as logistic regression (LR) and Cox proportional hazards analysis. Some of

Lack of evidence for clinical utility of risk prediction models

The literature is teeming with HF risk prediction models; however, there is little evidence that incorporating risk prediction into clinical practice influences management or improves outcomes. Model development for the sake of prediction has become a popular educational hobby,47 but, in order for risk models to be used to improve processes of care, they should be interpretable and actionable. Most models include risk factors that are not modifiable (eg, age) and it is unclear what, if any,

Barriers to implementation of risk prediction models in clinical practice and systems of care

Despite all of the efforts to develop a well-validated risk prediction model for patients with HF, adoption of risk modeling to assess prognosis in clinical settings is low. Less than 1% of patients enrolled in a long-term HF registry were offered information regarding prognosis calculated from a risk model by their treating clinicians.18 One major reason for this is likely the lack of evidence for the clinical utility of implementation of HF risk scores; however, there are also several

Promise of artificial intelligence for risk prediction in heart failure

Rapid advances in computational power, the digital big data revolution, and innovations in mathematical algorithms have led to a recent resurgence of enthusiasm surrounding the utility of artificial intelligence in several industries. The recent popularity of artificial intelligence has been propelled by the development of novel machine learning (ML) models, which are computer algorithms designed to learn without explicit programming, instead relying on patterns and inference from data (Fig. 1

Summary and future directions

Predicting outcomes in patients with HF has proved difficult. Although many individual risk factors for adverse future outcomes are known, attempts at developing high-performing risk models in various HF populations using statistically based methods have generally underwhelming. Moreover, there is currently a lack of evidence to support the notion that implementation of these risk scores into clinical practice or systems of care improves outcomes. Newer methods of risk prediction using ML

Disclosure

S.J. Shah is supported by grants from the National Institutes of Health (R01 HL140731, R01 HL120728, R01 HL107577, and R01 HL149423); the American Heart Association (#16SFRN28780016, #15CVGPSD27260148); Actelion, AstraZeneca, Corvia, and Novartis; and has received consulting fees from Actelion, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Cardiora, Eisai, Ionis, Ironwood, Merck, Novartis, Pfizer, Sanofi, and United Therapeutics. F.S. Ahmad is supported in part by a grant from the Agency for

First page preview

First page preview
Click to open first page preview

References (145)

  • W.T. Abraham et al.

    Predictors of in-hospital mortality in patients hospitalized for heart failure. insights from the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF)

    J Am Coll Cardiol

    (2008)
  • C.M. O’Connor et al.

    Predictors of mortality after discharge in patients hospitalized with heart failure: An analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

    Am Heart J

    (2008)
  • M. Vaduganathan et al.

    Epidemiology of hospitalized heart failure. differences and similarities between patients with reduced versus preserved ejection fraction

    Heart Fail Clin

    (2013)
  • J.R. Kapoor et al.

    Precipitating clinical factors, heart failure characterization, and outcomes in patients hospitalized with heart failure with reduced, borderline, and preserved ejection fraction

    JACC Hear Fail

    (2016)
  • F.A. McAlister et al.

    Multidisciplinary strategies for the management of heart failure patients at high risk for admission: A systematic review of randomized trials

    J Am Coll Cardiol

    (2004)
  • B.B. Granger et al.

    Results of the chronic heart failure intervention to improve medication adherence study: A randomized intervention in high-risk patients

    Am Heart J

    (2015)
  • F.A. McAlister et al.

    A systematic review of randomized trials of disease management programs in heart failure

    Am J Med

    (2001)
  • L.M. Yamokoski et al.

    Prediction of rehospitalization and death in severe heart failure by physicians and nurses of the ESCAPE trial

    J Card Fail

    (2007)
  • T. Ahmad et al.

    Clinical implications of chronic heart failure phenotypes defined by cluster analysis

    J Am Coll Cardiol

    (2014)
  • C.M. Wong et al.

    Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (candesartan in heart failure assessment of reduction in mortality and morbidity)

    J Am Coll Cardiol

    (2013)
  • G.F. Romiti et al.

    Sex and gender-related issues in heart failure

    Heart Fail Clin

    (2020)
  • P. Glynn et al.

    Disparities in cardiovascular mortality related to heart failure in the United States

    J Am Coll Cardiol

    (2019)
  • M.R.G. Taylor et al.

    Natural history of dilated cardiomyopathy due to lamin A/C gene mutations

    J Am Coll Cardiol

    (2003)
  • D.B. Taichman et al.

    Wide variation in clinicians’ assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension

    Mayo Clin Proc

    (2009)
  • L.W. Stevenson et al.

    INTERMACS profiles of advanced heart failure: the current picture

    J Heart Lung Transplant

    (2009)
  • M. Valentova et al.

    Cardiac cachexia revisited: the role of wasting in heart failure

    Heart Fail Clin

    (2020)
  • D.M. Shindler et al.

    Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) trials and registry

    Am J Cardiol

    (1996)
  • A. Xanthopoulos et al.

    Heart failure and liver disease: cardiohepatic interactions

    JACC Hear Fail

    (2019)
  • M.R. Costanzo

    The cardiorenal syndrome in heart failure

    Heart Fail Clin

    (2020)
  • C.S.P. Lam et al.

    Minding the gap in heart failure. Understanding the pulse pressure in reduced versus preserved ejection fraction

    JACC Hear Fail

    (2016)
  • M.H. Chin et al.

    Correlates of early hospital readmission or death in patients with congestive heart failure

    Am J Cardiol

    (1997)
  • T.T. Lee et al.

    The association between blood pressure and mortality in patients with heart failure

    Am Heart J

    (2006)
  • K. Fox et al.

    Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

    Lancet

    (2008)
  • M. Obeidat et al.

    Atrial fibrillation in heart failure: focus on antithrombotic management

    Heart Fail Clin

    (2020)
  • S.S. Virani et al.

    Heart Disease and Stroke Statistics-2020 Update A Report From the American Heart Association

    Circulation

    (2020)
  • C.W. Yancy et al.

    2013 ACCF/AHA guideline for the management of heart failure: A report of the american college of cardiology foundation/american heart association task force on practice guidelines

    Circulation

    (2013)
  • P.A. Heidenreich et al.

    Forecasting the impact of heart failure in the united states a policy statement from the american heart association

    Circ Heart Fail

    (2013)
  • G.C. Fonarow et al.

    Risk stratification for in-hospital mortality in acutely decompensated heart failure: Classification and regression tree analysis

    J Am Med Assoc

    (2005)
  • P.N. Peterson et al.

    A validated risk score for in-hospital mortality in patients with heart failure from the American heart association get with the guidelines program

    Circ Cardiovasc Qual Outcomes

    (2010)
  • G.S. Collins et al.

    Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement

    Ann Intern Med

    (2015)
  • K.G.M. Moons et al.

    Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): Explanation and elaboration

    Ann Intern Med

    (2015)
  • D.M. Lloyd-Jones

    Cardiovascular risk prediction: Basic concepts, current status, and future directions

    Circulation

    (2010)
  • G.L. Di Tanna et al.

    Evaluating risk prediction models for adults with heart failure: A systematic literature review

    PLoS One

    (2020)
  • A.C. Alba et al.

    Risk prediction models for mortality in ambulatory patients with heart failure a systematic review

    Circ Heart Fail

    (2013)
  • W.C. Levy et al.

    The Seattle heart failure model: prediction of survival in heart failure

    Circulation

    (2006)
  • M. Packer et al.

    Effect of amlodipine on morbidity and mortality in severe chronic heart failure

    N Engl J Med

    (1996)
  • L.A. Allen et al.

    Use of risk models to predict death in the next year among individual ambulatory patients with heart failure

    JAMA Cardiol

    (2017)
  • S.J. Pocock et al.

    Predicting survival in heart failure: A risk score based on 39 372 patients from 30 studies

    Eur Heart J

    (2013)
  • U. Sartipy et al.

    Predicting survival in heart failure: Validation of the MAGGIC heart failure risk score in 51 043 patients from the Swedish Heart Failure Registry

    Eur J Heart Fail

    (2014)
  • J.D. Rich et al.

    Meta-analysis global group in chronic (MAGGIC) heart failure risk score: Validation of a simple tool for the prediction of morbidity and mortality in heart failure with preserved ejection fraction

    J Am Heart Assoc

    (2018)
  • Cited by (18)

    View all citing articles on Scopus
    View full text